Associations of socioeconomic variables with resection, stage, and survival in patients with early-stage pancreatic cancer

JAMA Surgery

Volumn 151, Issue 4, 2016, Pages 338-345

  Shapiro, Mia ^a,b   Chen, Qi ^b,c   Huang, Qin ^a,b   Boosalis, Valia A ^b,c   Yoon, Charles H ^a,d   Saund, Mandeep S ^a,e,f   Whang, Edward E ^a,b,d   Gold, Jason S ^a,b,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; COHORT ANALYSIS; DEMOGRAPHY; DISEASE SPECIFIC SURVIVAL; EARLY CANCER; EUROPEAN AMERICAN; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEALTH CARE DISPARITY; HEALTH INSURANCE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OUTCOME ASSESSMENT; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOCIOECONOMICS; ADENOCARCINOMA; CLINICAL TRIAL; EARLY DIAGNOSIS; ECONOMICS; FOLLOW UP; INCIDENCE; MASSACHUSETTS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PANCREAS RESECTION; PANCREATIC NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SURVIVAL RATE; TIME FACTOR; TRENDS;

ADENOCARCINOMA; AGED; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INSURANCE, HEALTH; MALE; MASSACHUSETTS; MIDDLE AGED; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 84965047884     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2015.4239     Document Type: Article

References (18)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5-29.
2. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913-2921.
3. Zell JA, Rhee JM, Ziogas A, Lipkin SM, Anton-Culver H. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev. 2007;16(3):546-552.
4. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg. 2007;246(2):173-180.
5. Riall TS, Townsend CM Jr, Kuo YF, Freeman JL, Goodwin JS. Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process. Cancer. 2010;116(4):930-939.
6. Baine M, Sahak F, Lin C, Chakraborty S, Lyden E, Batra SK. Marital status and survival in pancreatic cancer patients: a SEER based analysis. PLoS One. 2011;6(6):e21052.
7. Aizer AA, Chen MH, McCarthy EP, et al. Marital status and survival in patients with cancer. J Clin Oncol. 2013;31(31):3869-3876.
8. Smith JK, Ng SC, Zhou Z, et al. Does increasing insurance improve outcomes for US cancer patients? J Surg Res. 2013;185(1):15-20.
9. McGhan LJ, Etzioni DA, Gray RJ, Pockaj BA, Coan KE, Wasif N. Underuse of curative surgery for early stage upper gastrointestinal cancers in the United States. J Surg Res. 2012;177(1):55-62.
10. Murphy MM, Simons JP, Hill JS, et al. Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma. Cancer. 2009;115(17):3979-3990.
11. Murphy MM, Simons JP, Ng SC, et al. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma. Ann Surg Oncol. 2009; 16(11):2968-2977.
12. Shah A, Chao KS, Ostbye T, et al. Trends in racial disparities in pancreatic cancer surgery. J Gastrointest Surg. 2013;17(11):1897-1906.
13. Shavers VL, Harlan LC, Jackson M, Robinson J. Racial/ethnic patterns of care for pancreatic cancer. J Palliat Med. 2009;12(7):623-630.
14. Singal V, Singal AK, Kuo YF. Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis. J Cancer Res Clin Oncol. 2012;138(4):715-722.
15. Silverman DT, Hoover RN, Brown LM, et al.Why do black Americans have a higher risk of pancreatic cancer than white Americans? Epidemiology. 2003; 14(1):45-54.
16. Abraham A, Al-Refaie WB, Parsons HM, Dudeja V, Vickers SM, Habermann EB. Disparities in pancreas cancer care. Ann Surg Oncol. 2013;20(6): 2078-2087.
17. Edwards BK, Noone AM, Mariotto AB, et al. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014; 120(9):1290-1314.
18. Eppsteiner RW, Csikesz NG, McPhee JT, Tseng JF, Shah SA. Surgeon volume impacts hospital mortality for pancreatic resection. Ann Surg. 2009; 249(4):635-640.